BlackRock Japan’s Lexicon Pharmaceuticals LXRX Stock Holding History

BlackRock Japan’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$145K	Buy	10,514 +7,492	+248%	+$120K	﹤0.01%	830
2016 Q3	$55K	Buy	+3,022	New	+$48.6K	﹤0.01%	977
2016 Q2	–	Sell	-886	Closed	-$11K	–	1463
2016 Q1	$11K	Hold	886	–	–	﹤0.01%	1278
2015 Q4	$12K	Hold	886	–	–	﹤0.01%	1245
2015 Q3	$10K	Buy	+886	New	+$9.68K	﹤0.01%	1167

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Japan's LXRX Position: Q4 2016 in Review

BlackRock Japan increased its Lexicon Pharmaceuticals (LXRX) stake by 248% in Q4 2016, buying an estimated $120K and bringing the position to 10,514 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #830.

BlackRock Japan first reported a position in LXRX in Q3 2015 and has held it in 5 quarters since. 146 funds tracked by Wall St. Rank hold LXRX as of Q4 2016.

BlackRock Japan held 10,514 shares of Lexicon Pharmaceuticals worth $145K as of Q4 2016.
BlackRock Japan bought 7,492 Lexicon Pharmaceuticals shares in Q4 2016, an estimated $120K.
Lexicon Pharmaceuticals made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #830 holding.
BlackRock Japan first reported a position in Lexicon Pharmaceuticals in Q3 2015 and has held it in 5 quarters since.
146 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.